Publicacións (29) Publicacións de Luis Lima Rodríguez

2018

  1. Regulation of energy expenditure and brown/beige thermogenic activity by interleukins: New roles for old actors

    International Journal of Molecular Sciences, Vol. 19, Núm. 9

2015

  1. Divergent responses to thermogenic stimuli in BAT and subcutaneous adipose tissue from interleukin 18 and interleukin 18 receptor 1-deficient mice

    Scientific Reports, Vol. 5

2014

  1. Energy balance regulating neuropeptides are expressed through pregnancy and regulated by interleukin-6 deficiency in mouse placenta

    International Journal of Endocrinology, Vol. 2014

2013

  1. Interleukin 6 Deficiency Modulates the Hypothalamic Expression of Energy Balance Regulating Peptides during Pregnancy in Mice

    PLoS ONE, Vol. 8, Núm. 8

2009

  1. Identification and functional characterization of two novel activating thyrotropin receptor mutants in toxic thyroid follicular adenomas.

    Thyroid : official journal of the American Thyroid Association, Vol. 19, Núm. 6, pp. 645-649

1995

  1. Clonidine potentiates the growth hormone response to a growth hormone releasing hormone challenge in hypothalamic growth hormone releasing hormone deficient rats

    Neuroendocrinology, Vol. 61, Núm. 5, pp. 552-558

1993

  1. Clonidine potentiates the growth hormone (GH) response to GH-releasing hormone in norepinephrine synthesis-inhibited rats: Evidence for an alpha-2-adrenergic control of hypothalamic release of somatostatin

    Neuroendocrinology, Vol. 57, Núm. 6, pp. 1155-1160

  2. Glucocorticoids may inhibit growth hormone release by enhancing β-adrenergic responsiveness in hypothalamic somatostatin neurons

    Journal of Clinical Endocrinology and Metabolism, Vol. 76, Núm. 2, pp. 439-444

  3. Studies on α2-adrenergic modulation of hypothalamic somatostatin secretion in rats

    Life Sciences, Vol. 53, Núm. 8, pp. 665-668

1992

  1. Neuroendocrine control of growth hormone secretion in humans

    Trends in Endocrinology and Metabolism

1991

  1. Clonidine pretreatment modifies the growth hormone secretory pattern induced by shortterm continuous GRF infusion in normal man

    Clinical Endocrinology, Vol. 35, Núm. 2, pp. 129-135

  2. Evidence that α2-Adrenergic pathways play a major role in growth hormone (GH) neuroregulation: α2-Adrenergic agonism counteracts the inhibitory effect of muscarinic cholinergic receptor blockade on the GH Response to GH-Releasing Hormone, while α2-Adrenergic blockade diminishes the potentiating effect of increased cholinergic tone on such stimulation in normal men

    Journal of Clinical Endocrinology and Metabolism, Vol. 73, Núm. 2, pp. 251-256

  3. Growth hormone and aging

    Endocrinologia, Vol. 38, Núm. 8, pp. 254-260

  4. Role of central dopaminergic pathways in the neural control of growth hormone secretion in normal men: Studies with metoclopramide

    Neuroendocrinology, Vol. 53, Núm. 2, pp. 143-149

  5. Testosterone and GHRH gene expression in adult and old rats

    Peptides, Vol. 12, Núm. 2, pp. 309-312

  6. The role of sexual steroids in the modulation of growth hormone (GH) secretion in humans

    Journal of Steroid Biochemistry and Molecular Biology, Vol. 40, Núm. 1-3, pp. 165-173

1990

  1. New concepts in the neuroregulation of growth hormone secretion

    Arquivos de Medicina, Vol. 3, Núm. 4, pp. 329-338

  2. α2-adrenergic agonism enhances the growth hormone (gh) response to gh-releasing hormone through an inhibition of hypothalamic somatostatin release in normal men

    Journal of Clinical Endocrinology and Metabolism, Vol. 71, Núm. 6, pp. 1581-1588

1989

  1. Controversies in the GH response to GHRH in man

    Recent advances in basic and clinical neuroendocrinology: proceedings of the 4th Meeting of the European Neuroendocrine Association. ICS864

  2. Estudio del ritmo endógeno hipotálamo somatotropo e influencia de los niveles circulantes de esteroides sexuales sobre la secreción de hormona de crecimiento

    Universidad de Santiago de Compostela